Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Riset: Proyek geotermal di sejumlah daerah lanjut terus meski banyak melanggar HAM

● Terdapat banyak pelanggaran HAM dalam pengembangan proyek geotermal di Indonesia.● Riset Pusham UII di antaranya menemukan pelanggaran hak atas partisipasi, hak-hak ekonomi, sosial, dan ...

Riset: Warga menilai MBG lebih menguntungkan elite dibanding rakyat

Spanduk Badan Gizi Nasional untuk program Makanan Bergizi Gratis di sebuah sekolah di Jakarta.wisely/Shutterstock● Manfaat MBG lebih dirasakan elite politik ketimbang penerimanya.● Program...

Bea parkir digabung ke pajak STNK: Praktis tapi berisiko merugikan

● Pemerintah sempat mewacanakan pajak STNK digabung dengan biaya parkir setahun.● Tarif yang ditawarkan tergolong murah, mulai dari Rp2 ribu per hari.● Tanpa persiapan yang baik, wac...